Agfa HealthCare announced that The National Naval Medical Center (NNMC) in Bethesda, MD, has chosen Agfa’s IMPAX™ PACS (Picture Archiving and Communications System).
HIMSS Dallas, TX, February 14, 2005
Agfa HealthCare announced that The National Naval Medical Center (NNMC) in Bethesda, MD, has chosen Agfa's IMPAX(TM) PACS (Picture Archiving and Communications System). The NNMC recently faced a cross-vendor data migration challenge when it switched from a legacy PACS system to a new IMPAX PACS. The NNMC chose Agfa for several reasons including the standards-based, vendor-neutral platform of IMPAX, the transition benefits of Agfa's Data Migration Service, and compatibility with other military hospitals in the National Capital Area.
The time in which Agfa migrated approximately four terabytes (150,000 studies) of the NNMC's archive of general diagnostic, CT and MRI images and RIS (Radiology Information System) data compared favorably to industry benchmarks. The NNMC deemed the process accurate, with Agfa's auto-validation tool saving the Navy significant time and cost. Now that the NNMC's migration of the largest repository of PACS data is complete, it is planning the migration of six years of ultrasound images and additional reports to IMPAX from a separate archive.
"Maintaining an old PACS system to provide access to legacy images is expensive and prevents an institution from maximizing the workflow benefits available with today's next-generation PACS offerings," said Adriano Rosa, Marketing Manager, Professional Services, Agfa HealthCare. "When replacing older image management systems with new, higher-performing PACS solutions, efficiencies in migrating legacy PACS image and RIS data are important considerations in order to cost-effectively maintain patient care continuity."
Key attributes of Agfa's Data Migration Service that contributed to the successful cross-vendor PACS image and RIS data transfer at NNMC included:
The ability to integrate with the IMPAX solutions already in place at the Walter Reed Army Medical Center in Washington, DC, and at the Malcolm Grow Medical Center at Andrews Air Force Base, MD, was also part of the NNMC's decision to switch to IMPAX. The IMPAX at NNMC will also be connected with Agfa's PACS and CR (Computed Radiography) solution at the U.S. Capitol Building in Washington, DC, where an imaging clinic administers to U.S. senators, congressmen and congresswomen, and visitors to the U.S. Capitol Building.
End of message
About Agfa
The Agfa-Gevaert Group is one of the world's leading imaging companies. Agfa develops, manufactures and markets analogue and digital systems, intended mainly for the graphics industry and the healthcare markets. Agfa's headquarters are in Mortsel, Belgium. The company is active in 40 countries and has agents in another 100 countries throughout the world. Together they achieved a turnover of 4,215 million euros in 2003.
Product and company information can be found on Agfa's home page on the World Wide Web at: www.agfa.com.
Agfa, the Agfa rhombus, IMPAX and See More. Do More. are trademarks of Agfa-Gevaert N.V., Belgium or its affiliates. All rights reserved.
Contacts:
Geertrui De Smet
Global PR Manager HealthCare
tel.: +32 (0) 3 444 73 06
fax: +32 (0) 3 444 72 85
e-mail: geertruidesmet@agfapress.com
Jeff Lewis
Media Relations Manager HealthCare, North America
tel.: 201-440-2500 x4192
e-mail: jeff.lewis@agfa.com
Johan Jacobs
Corporate Press Relations Manager
tel.: +32 (0)3 444 80 15
fax: +32 (0)3 444 74 85
e-mail: johan.jacobs@agfa.com
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
2 Commerce Drive
Cranbury, NJ 08512